EWTX

Edgewise Therapeutics, Inc. Common Stock#33 · 2024EPC

Yearly return

+143%

Peak return

+247%

Max drawdown

-36%

ADR (20 days)

+6.9%

Base

20 days / -21.1%

Prior run

+40%

Breakout volume

13.1x

Pivot

$21.04

Biotech-/Medtech-News mit binaerem Daten-, Zulassungs- oder Studiencharakter.

Healthcare · Healthcare & Biotech

Continue in the full Atlas

Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare EWTX with the current market directly.